Narita, T
Ri, M
Masaki, A
Mori, F
Ito, A
Kusumoto, S
Ishida, T
Komatsu, H
Iida, S
Article History
Received: 26 November 2014
Revised: 18 September 2015
Accepted: 13 October 2015
First Online: 4 December 2015
Competing interests
: MR received research funding from Celgene Co., Ltd. SI received research funding and declares honoraria from Janssen Pharmaceutical K.K. and Celgene Co., Ltd. SI also received research funding from Kyowa Hakko Kirin Co., Ltd, Chugai Pharmaceutical Co., Ltd, Bristol-Myers Squibb, Ono Pharmaceutical Co., Ltd, Nippon Kayaku Co., Ltd, Eli Lilly Japan K.K. and Bayer Yakuhin, Ltd. TI received Research funding from Kyowa Hakko Kirin Co., Ltd., Bayer Pharma AG and Celgene K.K. and received honoraria from Kyowa Hakko Kirin Co., Ltd.